Vitreomacular Interface Affects Anti-VEGF Injection Intervals For AMD

Ocular Surgery News

The presence of vitreomacular interface disease appears to significantly affect anti-VEGF injection intervals for treatment of age-related macular degeneration, according to a study presented here.
  • <<
  • >>

Comments